Peter Clark to Neoadjuvant Therapy
This is a "connection" page, showing publications Peter Clark has written about Neoadjuvant Therapy.
Connection Strength
1.418
-
Keegan KA, Resnick MJ, Clark PE. Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder. Curr Opin Oncol. 2012 May; 24(3):278-83.
Score: 0.402
-
Clark PE. Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer. Expert Rev Anticancer Ther. 2009 Jun; 9(6):821-30.
Score: 0.329
-
Clark PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, Inman BA, Kuban DA, Kuzel TM, Lele SM, Michalski J, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Richie JP, Sexton WJ, Shipley WU, Small EJ, Spiess PE, Trump DL, Wile G, Wilson TG, Dwyer M, Ho M. Bladder cancer. J Natl Compr Canc Netw. 2013 Apr 01; 11(4):446-75.
Score: 0.107
-
Morgan TM, Keegan KA, Clark PE. Bladder cancer. Curr Opin Oncol. 2011 May; 23(3):275-82.
Score: 0.094
-
Morgan TM, Clark PE. Bladder cancer. Curr Opin Oncol. 2010 May; 22(3):242-9.
Score: 0.088
-
Bischoff CJ, Clark PE. Bladder cancer. Curr Opin Oncol. 2009 May; 21(3):272-7.
Score: 0.082
-
Clark PE. Bladder cancer. Curr Opin Oncol. 2007 May; 19(3):241-7.
Score: 0.071
-
Gwynn ES, Clark PE. Bladder cancer. Curr Opin Oncol. 2006 May; 18(3):277-83.
Score: 0.066
-
Clark PE, Stein JP, Groshen SG, Cai J, Miranda G, Lieskovsky G, Skinner DG. Radical cystectomy in the elderly: Comparison of survival between younger and older patients. Cancer. 2005 Feb 01; 103(3):546-52.
Score: 0.061
-
Clark PE, Peereboom DM, Dreicer R, Levin HS, Clark SB, Klein EA. Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer. Urology. 2001 Feb; 57(2):281-5.
Score: 0.046
-
Burgess EF, Livasy C, Trufan S, Hartman A, Guerreri R, Naso C, Clark PE, Grigg C, Symanowski J, Raghavan D. High aurora kinase expression identifies patients with muscle-invasive bladder cancer who have poor survival after neoadjuvant chemotherapy. Urol Oncol. 2019 12; 37(12):900-906.
Score: 0.042
-
Gwynn ES, Clark PE, Hall MC. Recent advances in the treatment of bladder cancer. Expert Rev Anticancer Ther. 2005 Dec; 5(6):1023-30.
Score: 0.016
-
Borden LS, Clark PE, Hall MC. Bladder cancer. Curr Opin Oncol. 2003 May; 15(3):227-33.
Score: 0.013